Twenty-eight potential participants were screened. Three were excluded for depression or anxierty diagnoses, and one was excluded for absence of ADHD diagnosis. One participant was lost to follow-up, and the remaining 23 participants were enrolled in the study. Of the sample of 23, one withdrew due to unrelated illness, and three participants were not included due to protocol noncompliance with either the Actiwatch (N=2) or the light therapy (N=1), leaving a final sample of 19 participants who completed the protocol.